Welcome to Ohio State MD Connect
Hear from and connect with health care professionals from The Ohio State University Wexner Medical Center and The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James), sharing insights on the latest clinical innovations and advances in patient care. Access videos, articles, news, clinical trials and much more.
Ohio State University Wexner Medical Center gastroenterologist, Darrell Gray, II, MD, MPH discusses how COVID-19 has brought new focus and awareness on the long-standing inequities in health among black and indigenous people of color, ...
Daniel Gallego-Perez, Ph.D., extends regenerative medicine technology, called Tissue Nanotransfection (TNT), to the treatment of diabetes.
Matthew Kalady, MD explains the importance of patient-centered research to identify novel biomarkers for radiation resistance and potential therapeutic targets. Dr. Kalady explores targeted therapies, and presents clinical algorithms and ...
Joshua Englert, MD explains Acute Respiratory Distress Syndrome (ARDS) and describes its syndromic nature. Dr. Englert also reviews currents ARDS management during COVID-19, and identifies novel approaches to develop targeted ARDS therapies.
Thanks to their discovery of new antibody suppressor cells in animal models, Ohio State researchers have embarked on a promising investigation of how the cells play a role in further reducing organ transplant rejection in humans.
It’s an often-overlooked factor in managing diabetes, says Joshua Joseph, MD, but the stress hormone cortisol is clearly linked with higher blood sugar levels in people with type 2 diabetes.